Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A new compound was made that might help treat diseases related to male hormones.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.